Navigation Links
Helix BioPharma Announces Q1 2009 Financial Results
Date:12/11/2008

64 66 Amortization of intangibles 3 7 Stock-based compensation - 12 Foreign exchange loss 150 108 (2,104) (1,451) Change in non-cash working capital 486 (192) Operating activities (1,618) (1,643) Financing activities 9,659 - Investing activities (37) (50) Effect of exchange rate changes on cash and cash equivalents (150) (108) Increase in cash and cash equivalents 7,854 (1,801) Cash and cash equivalents: Beginning of the period 19,057 11,379 End of the period 26,911 9,578 

    Consolidated Balance Sheets as at
     ($ thousands)
                                             31-Oct      31-Jul
                                               2008       2008
       Current assets:
        Cash and cash
         equivalents                         26,911      19,057
        Accounts receivable                     500         349
        Inventory                               521         458
        Prepaid and other                       222         446
        Deferred financing
         costs                                    -           -
                                             28,154      20,310

       Non current assets                     1,266       1,356

                                             29,420      21,666



                                             31-Oct      31-Jul
                                              2008        2008
     Current liabilities:
      Accounts payable                         
'/>"/>
SOURCE  Helix BioPharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. Helix BioPharma announces $16.9 million private placement of common shares
6. Helix BioPharma announces Q1 2008 financial results
7. Helix BioPharma closes $16.9 million private placement of common shares
8. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
9. Helix BioPharma shareholders vote in favour of management
10. Helix BioPharma reports Q2 2008 highlights, financial results
11. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2
... , , , , , , , For pur...volumes , , , , ..., , , , Fo... , Throughput: , 124 sam...range: , 70 bp 4 kb*, , ...
... , , , , , , , For ro..., , , , , , , ... Concentration , , , ..., , , , H...5 units/l , , , PCR ...
... , , , , , , , QIAG...System for cost-effective, fully automated, high-t... plasmids. Use of a novel lysis chemistry eliminat...lasmid DNA purification is performed using , ...ure. The protocol , is faster and easier to...
Other Biology Technology:DirectPrep 96 Miniprep System for cost-effective, high-throughput plasmid , DNA purification 2DirectPrep 96 Miniprep System for cost-effective, high-throughput plasmid , DNA purification 3DirectPrep 96 Miniprep System for cost-effective, high-throughput plasmid , DNA purification 4
(Date:12/3/2009)Forest dwellers must be included in the design of the upcoming forest deal at Copenhagen in order to avoid a humanitarian crisis, according to a scientist at the University of Leeds. , Writing today
(Date:12/3/2009)The UK leads the world when it comes to investment in energy efficient technologies research, but Engineering and Physical Sciences Research Council (EPSRC) Chief Executive Dave Delpy believes that mo
(Date:12/3/2009)The 30-year record low in Antarctic snowmelt that occurred during the 2008-09 austral summer was likely due to concurrent strong positive phases for two main climate drivers, ENSO (El Nio - Southern O
Breaking Biology News(10 mins):Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Research is vital to a cleaner, greener, low carbon future 2CCNY professor foresees rising Antarctic snowmelt 2Air Pollution May Cause Appendicitis 3A Study 58869 1Air Pollution May Cause Appendicitis 3A Study 58869 2Air Pollution May Cause Appendicitis 3A Study 58869 38 Ounces a Day of POM Wonderful 100 25 Pomegranate Juice May Slow Progression of Carotid Intima Media Thickness 28CIMT 29 in Patients with Elevated C 58866 18 Ounces a Day of POM Wonderful 100 25 Pomegranate Juice May Slow Progression of Carotid Intima Media Thickness 28CIMT 29 in Patients with Elevated C 58866 28 Ounces a Day of POM Wonderful 100 25 Pomegranate Juice May Slow Progression of Carotid Intima Media Thickness 28CIMT 29 in Patients with Elevated C 58866 3Super Jake Foundation Hosts 5th Annual Heroes Bash on Nov 14 to Benefit Pediatric Cancer Research 58863 1Super Jake Foundation Hosts 5th Annual Heroes Bash on Nov 14 to Benefit Pediatric Cancer Research 58863 2
...iscovered that the genetic malfunction that causes...me (NS) produces an imbalance in the genesis of tw.... This imbalance, they theorize, could explain how...pathology of the disorder. More broadly, they said... could apply to other inherited forms of retardati...
...strategies are needed because more and more bacter...s are not effective at eradicating chronic bacteri...bacterial strategies, taken by researchers from th...he amount of iron (Fe), which is critical for bact...the study, which appears online on March 15 in adv...
...oduce useful proteins could be an inexpensive alte...searchers from the Flanders Interuniversity Instit...ve succeeded in producing in plant seeds proteins ... They have also demonstrated that these antibody v... that occur naturally in humans. By virtue of thei...
Other Biology News:How genetic malfunction causes a form of retardation 2Producing medicines in plant seeds 2Producing medicines in plant seeds 3
... assess the effect of drugs on the motor coordinat...ne unit in a safe and humane way. Extremely user f...to avoid slipping. When an animal drops onto the i...s are recorded. • IITCs Rotarod test has the ...
...F2α (8-iso-13,14-dihydro-15-keto PGF2;...ane (8-iso PGF2α), in rabbits, monkeys and ... non-specific lipid peroxidation. In both humans a...onverted primarily to metabolites having 2 or 4 ca...
... rhinovirus (HRV 3C) is the newest addition to the.... The recombinant protease is a highly purified re...he same cleavage site as the native enzyme: LeuGlu... protease, optimal activity at 4° C, high spec...
Human gamma-Globulin, Unconjugated from Calbiochem
Biology Products: